Sage Journals: Discover world-class research

Abstract

Purpose

The aim of our work was to explore which of the most commonly used pain scales is best suited to assess treatment success in endometriosis therapy and, therefore, qualifies best to be used as primary endpoint for clinical studies in this indication.

Methods

We compared patient's responses on the different pain scales Visual Analog Scale, Biberoglu and Behrman Score, and SF-36 Bodily Pain Subscale with the Clinical Global Impression score. Parametric and non-parametric correlation coefficients and effect sizes were calculated.

Results

A total of 428 patients with endometriosis-associated pelvic pain from three studies were included in our analyses. Their mean age was 31.4±6.3 years and their mean pain score on the visual analog scale was 58.1±21.9 at baseline. The highest correlation with the Clinical Global Impression score was observed for the visual analog scale followed by the B&B pelvic pain item. The highest effect sizes were found for dysmenorrhea and SF-36 bodily pain subscale followed by the visual analog scale.

Conclusions

A general measure of endometriosis-related pain can be recommended as primary endpoint in clinical trials to assess painful symptoms of endometriosis. In addition, a disease-specific quality of life tool is recommended to help interpret impact on patients’ daily activities.

Keywords

Effect size Endometriosis Pelvic pain Visual analogue scale

Get full access to this article

View all access options for this article.

References

Kennedy

, Bergqvist

, Chapron

ESHRE guideline for the diagnosis and treatment of endometriosis.

Hum Reprod 2005; 20: 2698–704.

Practice Committee of American Society for Reproductive Medicine.

Treatment of pelvic pain associated with endometriosis.

Fertil Steril 2008; 90: S260–9.

Bernuit

D E.A.

, Halis

, Strothmann

, Gerlinger

, Geppert

, Faustmann

. Female perspectives on endometriosis: findings from the uterine bleeding and pain women's research study. J Endometr 2011; 3: 73–85.

Biberoglu

K.O.

, Behrman

S.J.

. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol 1981 15; 139: 645–54.

Strowitzki

, Marr

, Gerlinger

, Faustmann

, Seitz

. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010; 25: 633–41.

Guzick

D.S.

, Huang

L.S.

, Broadman

B.A.

, Nealon

, Hornstein

M.D.

. Randomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic pain. Fertil Steril 2011; 95: 1568–73.

Vincent

, Kennedy

, Stratton

. Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting. Fertil Steril 2010; 93: 62–7.

Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on Clinical Investigation of Medicinal Products for treatment of nociceptive pain (CPMP/EWP/612/00). London: EMEA, 2002.

Food and Drug Administration CfDEaR. Statistical Review(s). Depo-subQ provera 104TM. Medroxyprogesterone acetate injectable suspension 104 mg/0.65 mL. 2005.

10.

Harada

, Momoeda

, Taketani

Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis– a randomized, double-blind, multicenter, controlled trial.

Fertil Steril 2009; 91: 675–81.

11.

Strowitzki

, Faustmann

, Gerlinger

, Seitz

. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010; 151: 193–8.

12.

Ware

JE K.M.

. SF-36 Physical and Mental Health Summary Scales: A Manual for Users of Version 1. 2nd edn. Lincoln, RI, USA: QualityMetric Incorporated; 2001.

13.

Stull

D W.R.

, Kreif

, Colligs

, Seitz

, Gerlinger

. Validation of the SF-36 in patients with endometriosis. Value Health 2009; 12: A295.

14.

Guy

. Clinical Global Impressions. In: (ADM)

D.P.

, editor. ECDEU Assessment Manual for Psychopharmacology. Rockville, MD: National Institute for Mental Health 1976; 218–22.

15.

Revised American Fertility Society classification of endometriosis: 1985.

Fertil Steril 1985; 43: 351–2.

16.

Revised American Society for Reproductive Medicine classification of endometriosis: 1996.

Fertil Steril 1997; 67: 817–21.

17.

U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research Center for Biologics Evaluation and Research Center for Devices and Radiological Health. Guidance for Industry. Patient-reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims. Rockville, MD2009.

18.

Gerlinger

, Schumacher

, Faustmann

, Colligs

, Schmitz

, Seitz

. Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: analyses of two placebo-controlled, randomized trials. Health Qual Life Outcomes 2010; 8: 138.

19.

Ahlers

S.J.

, van Gulik

, van der Veen

A.M.

Comparison of different pain scoring systems in critically ill patients in a general ICU.

Crit Care 2008; 12(1): R15.

20.

Vincent

. Pelvic pain in women: clinical and scientific aspects. Curr Opin Support Palliat Care 2011; 5: 143–9.

How can we measure endometriosis-associated pelvic pain?

Abstract

Purpose

Methods

Results

Conclusions

Keywords

Get full access to this article

References